S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S- (dimethylarsino) glutathione as treatments for cancer

Mérida Sotelo Lerma; R. A. Zingaro

S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S- (dimethylarsino) glutathione as treatments for cancer

Mérida Sotelo Lerma (Inventor), R. A. Zingaro (Inventor)

Departamento de Investigación en Polímeros y Materiales

Research output: Patent

Abstract

Abstract: Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of inorganic arsenic in vivo

Original language	English
Patent number	07619000
IPC	US,20080090904
Priority date	7/01/02
Filing date	6/06/09
State	Published - 17 Apr 2003

Cite this

@misc{e496f1c23df14767aa7ad4808e07db39,

title = "S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S- (dimethylarsino) glutathione as treatments for cancer",

abstract = "Abstract: Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of inorganic arsenic in vivo",

author = "{Sotelo Lerma}, M{\'e}rida and Zingaro, {R. A.}",

year = "2003",

month = apr,

day = "17",

language = "Ingl{\'e}s",

publisher = "The Texas A&M University System",

type = "Patent",

note = "07619000; US,20080090904",

}

TY - PAT

T1 - S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S- (dimethylarsino) glutathione as treatments for cancer

AU - Sotelo Lerma, Mérida

AU - Zingaro, R. A.

PY - 2003/4/17

Y1 - 2003/4/17

N2 - Abstract: Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of inorganic arsenic in vivo

AB - Abstract: Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of inorganic arsenic in vivo

M3 - Patente

M1 - 07619000

Y2 - 2009/06/06

PB - The Texas A&M University System

ER -